Tags: Drug.
Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of March 2010 it is undergoing Phase II/III clinical trials.
Loading...
This page contains content from the copyrighted Wikipedia article "Pagibaximab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.